P397: Efficacy and safety of sequential rescue therapy with infliximab and tacrolimus in patients with corticosteroid-refractory ulcerative colitisECCO '16 Amsterdam
2016
P398: The costs of care for patients with ulcerative colitis: effect of adalimumab on health care resources utilisation in clinical practice from INSPIRADAECCO '16 Amsterdam
2016
P400: Anti-TNF treatment for extraintestinal manifestations of inflammatory bowel disease in the Swiss IBD Cohort StudyECCO '16 Amsterdam
2016
P401: Confocal laser endomicroscopy predicts response in patients with acute inflammatory bowel disease undergoing anti-integrin therapy with vedolizumabECCO '16 Amsterdam
2016
P404: Real-life experience with golimumab in ulcerative colitis patients according to prior anti-TNF useECCO '16 Amsterdam
2016
P406: AlphaE+ cells have increased expression of inflammatory markers and are correlated in the ileum and colonECCO '16 Amsterdam
2016
P407: Clinical manifestations of thiopurine S-methyltransferase variants in Korean paediatric patients with inflammatory bowel diseaseECCO '16 Amsterdam
2016
P408: Are pharmacokinetics more unfavourable in inflammatory bowel disease patients aged over 60 years?ECCO '16 Amsterdam
2016
P409: Impact of biological therapy in postoperative morbidity in elective surgical resections in Crohn’s diseaseECCO '16 Amsterdam
2016
P410: Segmental endoscopic scoring improves outcome prediction in acute severe colitisECCO '16 Amsterdam
2016
P411: Four-year efficacy and safety of azathioprine treatment in the maintenance of steroid-free remission in inflammatory bowel disease patientsECCO '16 Amsterdam
2016
P412: Evolution of patients with ulcerative colitis who withdraw the maintenance treatment with mesalazineECCO '16 Amsterdam
2016
P413: Endoscopic balloon dilatation of Crohn’s strictures is safe and effective in selected casesECCO '16 Amsterdam
2016
P414: Usefulness of ultrasonography in the assessment of postoperative recurrence of Crohn’s diseaseECCO '16 Amsterdam
2016